Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Jill Foss Watson CACC Credit Acceptance Corp 13D/A 14.1% 2y
BAKER BROS. ADVISORS LP MDGL Madrigal Pharmaceuticals, Inc. 13D/A 9.99% 2y
ETFS Capital Limited. WT WisdomTree, Inc. 13D/A 10% 2y
Redmile Group, LLC FATE Fate Therapeutics Inc 13D/A 14.9% 2y
Samsara BioCapital, L.P. LENZ LENZ Therapeutics, Inc. 13G/A 4.8% 2y
MEITAV INVESTMENT HOUSE LTD FORTY Formula Systems (1985) Ltd 13G/A 5.01% 2y
Millennium Management LLC MXCT Maxcyte, Inc. 13G 5.5% 2y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 7.2% 2y
FEDERATED HERMES, INC. FUSN Fusion Pharmaceuticals Inc. Common Shares 13D 12.65% 2y
Exor N.V. NG Novagold Resources Inc 13G 5% 2y
Divisar Capital Management LLC ADTN ADTRAN Holdings, Inc. 13G 5.5% 2y
AMR Action Fund, L.P. HLSQ Tessera Defense & Homeland Security Inc. 13G 5.5% 2y
S.H.N. Financial Investments Ltd. CISS C3is Inc. 13G 9.99% 2y
James J. Pallotta AIRJ AirJoule Technologies Corp. 13G 7.15% 2y
CONTINENTAL GENERAL INSURANCE CO DQ Daqo New Energy Corp. 13G 6.5% 2y
Jacob Shemer PKBK Parke Bancorp, Inc. 13D/A 5.17% 2y
Mink Brook Asset Management LLC STRR Star Equity Holdings, Inc. 13G 6.39% 2y
Investment Corporation of Dubai NDAQ Nasdaq, Inc. 13D/A 10.1% 2y
ORBIMED ADVISORS LLC CMPX Compass Therapeutics, Inc. 13D/A 13.7% 2y
Pfizer Inc HLN Haleon plc 13D/A 22.6% 2y
Viessmann Generations Group GmbH & Co. KG CARR CARRIER GLOBAL Corp 13D/A 6.53% 2y
Alibaba Group Holding Ltd XPEV Xpeng Inc. 13D/A 4.9% 2y
The Donald A. Foss 2009 Remainder Trust CACC Credit Acceptance Corp 13D/A 20.9% 2y
Hein Park Capital Management LP DBD DIEBOLD NIXDORF, Inc 13D/A 8.15% 2y
Millstreet Capital Management LLC DBD DIEBOLD NIXDORF, Inc 13D/A 17.24% 2y
ESL Partners, L.P. AN Autonation, Inc. 13D/A 9.99% 2y
D. Kyle Cerminara BKTI BK Technologies Corp 13G 5.9% 2y
Silver Lake Group, L.L.C. DELL Dell Technologies Inc. 13D/A 21.7% 2y
Barry John F PSEC Prospect Capital Corp 13D/A 26.25% 2y
Fortress Biotech, Inc. CKPT Checkpoint Therapeutics, Inc. Common Stock 13D/A 7.5% 2y
Camac Partners, LLC TSPH TuSimple Holdings Inc. 13D/A 5.1% 2y
THIRD AVENUE MANAGEMENT LLC TPHS Trinity Place Holdings Inc. 13D/A 6.44% 2y
Deerfield Management Company, L.P. HLSQ Tessera Defense & Homeland Security Inc. 13D 11.06% 2y
Headlands Capital Management, LLC NDLS NOODLES & Co 13D 5.4% 2y
Deep Track Capital, LP OLMA Olema Oncology, Inc. 13G 5.44% 2y
MILLENNIUM MANAGEMENT LLC AL SUMISHO AIR LEASE CORP 13G 0.2% 2y
Daniel Potter XTIA XTI Aerospace, Inc. 13G 10.4% 2y
Nadav Kidron ORMP Oramed Pharmaceuticals Inc. 13D 5.7% 2y
The ROP Revocable Trust dated 1/9/2018 VTVT vTv Therapeutics Inc. 13D/A 50.3% 2y
Darren Maupin SOC Sable Offshore Corp. 13G 12.6% 2y
WESTERLY CAPITAL MANAGEMENT, LLC HHS Harte Hanks Inc 13G/A 9.66% 2y
Standard General L.P. NCMI National CineMedia, Inc. 13G/A 0% 2y
Starboard Value LP AQN Algonquin Power & Utilities Corp. 13D/A 9% 2y
Sculptor Capital Management, Inc. GROV Grove Collaborative Holdings, Inc. 13D/A 4.21% 2y
D. Kyle Cerminara BKTI BK Technologies Corp 13D/A 6.7% 2y
Rosalind Advisors, Inc. BFRI Biofrontera Inc. 13G 9.9% 2y
Joel E. Cutler IOT Samsara Inc. 13D/A 12.61% 2y
ZUU Co. Ltd. SBC SBC Medical Group Holdings Inc 13D/A 27.5% 2y
Fund 1 Investments, LLC CTRN Citi Trends Inc 13D/A 19.4% 2y
ORBIMED ADVISORS LLC ACET Adicet Bio, Inc. 13D/A 11.9% 2y